DEHP-treated mice were protected from diet-induced obesity via PPARα-dependent activation of hepatic fatty acid catabolism, whereas the activity of neither PPARβ nor PPARγ was affected. The gene discussed is PPARD; the disease is obesity due to melanocortin 4 receptor deficiency.